96 related articles for article (PubMed ID: 12106983)
1. Controlled release of 4-nitroanisole from poly(lactic acid) nanoparticles.
Romero-Cano MS; Vincent B
J Control Release; 2002 Jul; 82(1):127-35. PubMed ID: 12106983
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight poly(lactic acid) microparticles for controlled release of the herbicide metazachlor: preparation, morphology, and release kinetics.
Stloukal P; Kucharczyk P; Sedlarik V; Bazant P; Koutny M
J Agric Food Chem; 2012 Apr; 60(16):4111-9. PubMed ID: 22480233
[TBL] [Abstract][Full Text] [Related]
3. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
4. Poly(lactic acid)-coated mesoporous silica nanosphere for controlled release of venlafaxine.
Tang J; Slowing II; Huang Y; Trewyn BG; Hu J; Liu H; Lin VS
J Colloid Interface Sci; 2011 Aug; 360(2):488-96. PubMed ID: 21640356
[TBL] [Abstract][Full Text] [Related]
5. Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel.
Lee LY; Wang CH; Smith KA
J Control Release; 2008 Jan; 125(2):96-106. PubMed ID: 18054107
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the diffusion-controlled release of papaverine from poly (L-lactic acid) matrix.
Miyajima M; Koshika A; Okada J; Kusai A; Ikeda M
J Control Release; 1998 Dec; 56(1-3):85-94. PubMed ID: 9801432
[TBL] [Abstract][Full Text] [Related]
7. Poly(lactic acid) (PLA) based nanocomposites--a novel way of drug-releasing.
Chen C; Lv G; Pan C; Song M; Wu C; Guo D; Wang X; Chen B; Gu Z
Biomed Mater; 2007 Dec; 2(4):L1-4. PubMed ID: 18458473
[TBL] [Abstract][Full Text] [Related]
8. Core-shell type polymeric nanoparticles composed of poly(L-lactic acid) and poly(N-isopropylacrylamide).
Kim IS; Jeong YI; Cho CS; Kim SH
Int J Pharm; 2000 Dec; 211(1-2):1-8. PubMed ID: 11137333
[TBL] [Abstract][Full Text] [Related]
9. [Preparation and drug release property of paclitaxel nanoparticles].
Wang TW; Wu Y; Li MJ; Gao HX
Zhong Yao Cai; 2009 Sep; 32(9):1447-9. PubMed ID: 20034226
[TBL] [Abstract][Full Text] [Related]
10. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.
Wang W; Chen S; Zhang L; Wu X; Wang J; Chen JF; Le Y
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of poly(lactic acid) nanoparticles for sustained release of pyridostigmine bromide.
Tan QY; Xu ML; Wu JY; Yin HF; Zhang JQ
Pharmazie; 2012 Apr; 67(4):311-8. PubMed ID: 22570937
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy.
Hrkach JS; Peracchia MT; Domb A; Lotan N; Langer R
Biomaterials; 1997 Jan; 18(1):27-30. PubMed ID: 9003893
[TBL] [Abstract][Full Text] [Related]
13. Novel surfactant for preparation of poly(L-lactic acid) nanoparticles with controllable release profile and cytocompatibility for drug delivery.
Li F; Zhu A; Song X; Ji L
Colloids Surf B Biointerfaces; 2014 Mar; 115():377-83. PubMed ID: 24503291
[TBL] [Abstract][Full Text] [Related]
14. Sustained release of drugs dispersed in polymer nanoparticles.
Jacobson GB; Shinde R; Contag CH; Zare RN
Angew Chem Int Ed Engl; 2008; 47(41):7880-2. PubMed ID: 18773393
[No Abstract] [Full Text] [Related]
15. Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release.
Thote AJ; Gupta RB
Nanomedicine; 2005 Mar; 1(1):85-90. PubMed ID: 17292062
[TBL] [Abstract][Full Text] [Related]
16. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
17. Preparation of polylactic acid microcapsules containing ciprofloxacin.
Yu WP; Wong JP; Chang TM
J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
[TBL] [Abstract][Full Text] [Related]
18. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
Nandakumar V; Geetha V; Chittaranjan S; Doble M
Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
[TBL] [Abstract][Full Text] [Related]
19. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
Kim HK; Park TG
J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anti-topoisomerase II activity by mucoadhesive 4-CBS-chitosan/poly (lactic acid) nanoparticles.
Songsurang K; Suvannasara P; Phurat C; Puthong S; Siraleartmukul K; Muangsin N
Carbohydr Polym; 2013 Nov; 98(2):1335-42. PubMed ID: 24053811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
